VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 162 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $928,745 | -61.6% | 99,119 | +0.7% | 0.01% | -61.9% |
| Q2 2023 | $2,415,665 | +18.0% | 98,478 | +11.9% | 0.02% | +16.7% |
| Q1 2023 | $2,047,132 | -10.3% | 87,973 | -2.5% | 0.02% | -10.0% |
| Q4 2022 | $2,283,266 | +63.6% | 90,212 | +24.6% | 0.02% | +53.8% |
| Q3 2022 | $1,396,000 | -41.4% | 72,418 | -22.6% | 0.01% | -43.5% |
| Q2 2022 | $2,383,000 | +511.0% | 93,544 | +516.6% | 0.02% | +475.0% |
| Q1 2022 | $390,000 | -94.4% | 15,170 | -90.5% | 0.00% | -94.0% |
| Q3 2021 | $6,967,000 | -13.7% | 160,089 | -6.3% | 0.07% | -5.6% |
| Q2 2021 | $8,074,000 | -23.7% | 170,779 | -17.3% | 0.07% | -31.1% |
| Q1 2021 | $10,583,000 | +72.1% | 206,416 | -10.1% | 0.10% | +49.3% |
| Q4 2020 | $6,150,000 | +10.6% | 229,652 | +41.7% | 0.07% | -15.9% |
| Q3 2020 | $5,562,000 | -15.6% | 162,029 | +0.7% | 0.08% | -6.8% |
| Q2 2020 | $6,589,000 | – | 160,827 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |